| Literature DB >> 30632851 |
Xuanfeng Ding1, Jun Zhou1, Xiaoqiang Li1, Kevin Blas1, Gang Liu1,2,3, Yinan Wang1, An Qin1, Prakash Chinnaiyan1, Di Yan1, Craig Stevens1, Inga Grills1, Peyman Kabolizadeh1.
Abstract
This feasibility study shows that Spot-scanning Proton Arc therapy (SPArc) is able to significantly reduce the dose to the hippocampus and cochlea compared to both Volumetric Modulated Arc Photon Therapy (VMAT) and the robust optimized Intensity Modulated Proton Therapy (ro-IMPT) plans in whole brain radiotherapy. Furthermore, SPArc not only improves plan robustness but could potentially deliver a treatment as efficient as ro-IMPT when proton system's energy layer switch time is less than 1 s.Mesh:
Year: 2019 PMID: 30632851 DOI: 10.1080/0284186X.2018.1555374
Source DB: PubMed Journal: Acta Oncol ISSN: 0284-186X Impact factor: 4.089